LNA Santé Future Growth
Future criteria checks 2/6
LNA Santé is forecast to grow earnings and revenue by 7.4% and 8.9% per annum respectively. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be 7.9% in 3 years.
Key information
7.4%
Earnings growth rate
6.5%
EPS growth rate
Healthcare earnings growth | 27.7% |
Revenue growth rate | 8.9% |
Future return on equity | 7.9% |
Analyst coverage | Low |
Last updated | 08 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 948 | 29 | 107 | 139 | 3 |
12/31/2025 | 882 | 27 | 105 | 129 | 3 |
12/31/2024 | 798 | 25 | 89 | 115 | 4 |
6/30/2024 | 762 | 24 | 108 | 120 | N/A |
3/31/2024 | 749 | 24 | 96 | 109 | N/A |
12/31/2023 | 736 | 23 | 85 | 98 | N/A |
9/30/2023 | 734 | 24 | 68 | 82 | N/A |
6/30/2023 | 732 | 24 | 52 | 66 | N/A |
3/31/2023 | 730 | 25 | 71 | 84 | N/A |
12/31/2022 | 728 | 26 | 90 | 103 | N/A |
9/30/2022 | 720 | 26 | 101 | 114 | N/A |
6/30/2022 | 711 | 26 | 113 | 125 | N/A |
3/31/2022 | 700 | 25 | 90 | 102 | N/A |
12/31/2021 | 689 | 24 | 66 | 80 | N/A |
9/30/2021 | 662 | 20 | 82 | 96 | N/A |
6/30/2021 | 634 | 16 | 98 | 112 | N/A |
3/31/2021 | 604 | 12 | 116 | 129 | N/A |
12/31/2020 | 574 | 8 | 133 | 147 | N/A |
9/30/2020 | 562 | 10 | 119 | 131 | N/A |
6/30/2020 | 551 | 13 | 104 | 115 | N/A |
3/31/2020 | 539 | 17 | 108 | 117 | N/A |
12/31/2019 | 528 | 21 | 112 | 118 | N/A |
9/30/2019 | 531 | 21 | 99 | 107 | N/A |
6/30/2019 | 534 | 22 | 87 | 95 | N/A |
3/31/2019 | 536 | 22 | 63 | 72 | N/A |
12/31/2018 | 539 | 22 | 39 | 48 | N/A |
9/30/2018 | 522 | 23 | 42 | 51 | N/A |
6/30/2018 | 505 | 25 | 45 | 53 | N/A |
3/31/2018 | 496 | 25 | N/A | 57 | N/A |
12/31/2017 | 487 | 24 | N/A | 61 | N/A |
9/30/2017 | 492 | 24 | N/A | 59 | N/A |
6/30/2017 | 497 | 24 | N/A | 58 | N/A |
3/31/2017 | 486 | 23 | N/A | 45 | N/A |
12/31/2016 | 475 | 22 | N/A | 32 | N/A |
9/30/2016 | 449 | 17 | N/A | 11 | N/A |
6/30/2016 | 423 | 13 | N/A | -10 | N/A |
3/31/2016 | 424 | 12 | N/A | 5 | N/A |
12/31/2015 | 425 | 11 | N/A | 20 | N/A |
9/30/2015 | 411 | 10 | N/A | 36 | N/A |
6/30/2015 | 398 | 9 | N/A | 52 | N/A |
3/31/2015 | 377 | 8 | N/A | 29 | N/A |
12/31/2014 | 356 | 7 | N/A | 7 | N/A |
9/30/2014 | 348 | 8 | N/A | 7 | N/A |
6/30/2014 | 340 | 8 | N/A | 7 | N/A |
3/31/2014 | 332 | 8 | N/A | 15 | N/A |
12/31/2013 | 324 | 8 | N/A | 23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2N3's forecast earnings growth (7.4% per year) is above the savings rate (1%).
Earnings vs Market: 2N3's earnings (7.4% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: 2N3's earnings are forecast to grow, but not significantly.
Revenue vs Market: 2N3's revenue (8.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2N3's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2N3's Return on Equity is forecast to be low in 3 years time (7.9%).